Drug intelligence / Profile preview

Biphenylalanine

Development stage
Preclinical
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
01

Overview

Biphenylalanine is an unnatural (non-standard) hydrophobic amino acid that serves as a crucial building block in the design and synthesis of various peptides and small molecules with therapeutic potential. Its incorporation often enhances properties such as cellular uptake, membrane interaction, and specific binding affinities. It has been utilized in the development of antimicrobial peptides, inhibitors for enzymes like plasmin and histone demethylase KDM4A, antagonists for integrins, and components for targeting cancer cells and cardiomyocytes. Additionally, it plays a significant role in genetic code expansion technologies, allowing for the site-specific incorporation of non-standard amino acids into proteins for research and biomanufacturing applications.

Other names
l-biphenylalanine4,4-L-biphenylalanine(2'-Et, 4'-OMe)4, 4'-L-biphenylalanine
02

Targets

αEβ7 (Integrin alphaEbeta7)KDM4A (Lysine-specific demethylase 4A)α4β1 (Integrin α4β1)PLG (Plasminogen)

Beyond the preview

Go deeper on Biphenylalanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biphenylalanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call